Sodium polystyrene sulfonate

DRUG3 trials

Sponsors

ZS Pharma, Inc., Maisonneuve-Rosemont Hospital, Alexandria University

Conditions

Chronic Kidney FailureHyperkalemia

Phase 4

Safety and Efficacy of Sodium Polystyrene Sulfonate in Hyperkalemia

TerminatedNCT01866709

ZS Pharma, Inc.Hyperkalemia

Start: 2013-05-31End: 2013-08-31Updated: 2014-09-03

Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients

CompletedNCT02065076

Maisonneuve-Rosemont HospitalChronic Kidney Failure, Hyperkalemia

Start: 2014-02-28End: 2014-10-31Target: 38Updated: 2014-10-03

Unknown Phase

SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis Patients

CompletedNCT06029179

Alexandria UniversityHyperkalemia

Start: 2024-01-15End: 2024-12-15Updated: 2025-02-11

Related Papers

Sodium zirconium cyclosilicate versus sodium polystyrene sulfonate for treatment of hyperkalemia in hemodialysis patients: a randomized clinical trial.

2025-05-061 citations